| Autor: |
Quaedvlieg, H.J.L., Polderman, F.N., Borkent, M., Jonge, De H.J.M., Annema, P.A., Derijks, L.J.J., Sikma, M.A., Bethlehem, C. |
| Zdroj: |
Current Drug Safety; 2023, Vol. 19 Issue: 2 p299-302, 4p |
| Abstrakt: |
Introduction: Mercaptopurine, a thiopurine, is used in various disorders of immune regulation, such as autoimmune hepatitis. Thiopurine metabolism is complex with risk for overdosing, especially when metabolism is impaired by liver dysfunction. Hepatotoxicity may be due to mercaptopurine overdose and is often reversible after prompt cessation of the drug. Case Presentation: Treatment of thiopurine toxicity is mainly supportive and literature on enhanced elimination by renal replacement therapy is ambiguous. Conclusion: In this case of thiopurine toxicity, a patient with autoimmune hepatitis presents with abdominal pain, nausea, vomiting, and diarrhea. We show in this case report that renal replacement therapy had no effect on total body clearance of mercaptopurine. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
